Recipharm adds development tools

Swedish-based CDMO Recipharm announced at CPHI that it is “expanding its pharmaceutical development capabilities through targeted investments and the integration of cutting-edge technologies”. This, it said, will bolster services at both early- and late- stage development, giving it fully integrated services that cover the whole life cycle of a molecule. These additions comprise:

* A new lab for sterile product development at the centre of excellence for NCE and generic small molecules at Bengaluru, India, which is also home to the extractables and leachables, nitrosamines and elemental impurities laboratories

* Advanced material characterisation equipment, a compression and compaction simulator, a Mini-Pactor for dry granulation, a pilot-scale capsule filler and a small-scale tablet press at both Bengaluru and the pilot-scale development centre in Zwickau, Germany

Recipharm has also added pre-clinical, clinical and pilot-scale sterile development capabilities for both small and large molecules at two more sites in Germay. These include a GMP VarioSys line for vials and pre-filled syringes at Wasserburg and GMP LAB+ equipment at Kaysersberg. It has other sites in France, India, Israel, Italy, Portugal, Spain, Sweden and the US.